![]() |
Product Name | AG-221 |
Product Page | Visit the Product |
Product Description | AG-221 (Enasidenib, CC-90007) is a potent and selective IDH2 inhibitor with potential anticancer activity. The mutations of IDH2 present in certain cancer cells result in a new ability of the enzyme to catalyze the NAPH-dependent reduction of ¦Á-ketoglutarate to R(-)-2-hydroxyglutarate (2HG). The production of 2HG is believed to contribute to the formation and progression of cancer. The inhibition of mutant IDH2 and its neoactivity is therefore a potential therapeutic treatment for cancer. |
Product Manual | Read Product Manual |
Price | Get info |
Specification | 1g, 2g, 5g, 10g |
Product Review | 0
![]() |
Vendor Information | ![]() MetonCHem Co., Ltd http://www.metonchem.com/ No.666 GaoXin Avenue, East Lake High-tech Development Zone Wuhan Hubei 430074 China Phone: 8613469958710 E-Mail: info@metonchem.com |